Page last updated: 2024-12-05

9,10-epoxystearic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9,10-Epoxystearic acid (ESA) is a fatty acid epoxide derived from oleic acid. It is a naturally occurring compound found in small amounts in various plant and animal sources. ESA can be synthesized via epoxidation of oleic acid using various reagents such as peracids or hydrogen peroxide. ESA exhibits several biological effects, including anti-inflammatory, anticancer, and antimicrobial activities. It has been shown to inhibit the growth of certain cancer cell lines and possesses promising potential as a therapeutic agent for inflammatory diseases. The unique structure of ESA, with its epoxide group, plays a crucial role in its biological activity. The epoxide ring can undergo ring-opening reactions, leading to the formation of various derivatives with different biological properties. The study of ESA is driven by its potential therapeutic applications and its role in understanding the complex biological pathways involving fatty acid epoxides. '

9,10-epoxystearic acid: RN given refers to parent cpd with unspecified isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

9,10-epoxyoctadecanoic acid : An epoxy fatty acid consisting of octadecanoic (stearic) acid with a single epoxide located between positions 9 and 10. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID15868
CHEMBL ID27918
CHEBI ID85661
SCHEMBL ID1326660
MeSH IDM0061322

Synonyms (39)

Synonym
2443-39-2
cis-3-octyl-oxiraneoctanoic acid
nsc179691
nsc-179691
wln: t3otj b8 c7vq
9,10-epoxyoctadecanoic acid
octadecanoic acid,10-epoxy-
9,10-epoxystearic acid
cis-9,10-epoxystearic acid
oxiraneoctanoic acid, 3-octyl-
nsc 179691
ai3-14196
einecs 219-477-3
oleic acid epoxide
octadecanoic acid, 9,10-epoxy-
3-octyloxiran-2-octanoic acid
8-(3-octyloxiran-2-yl)octanoic acid
theta, iot+c186a - epoxystearic acid
trans-9,10-epoxystearic acid, ~99% (capillary gc)
NCGC00161281-01
CHEMBL27918 ,
BML1-E12
epoxy-oleic acid
FT-0667937
FT-0667938
bdbm50280214
8-(3-octyl-oxiranyl)-octanoic acid
C19418
SCHEMBL1326660
AKOS024319383
00640uf4zm ,
unii-00640uf4zm
trans-9,10-epoxyoctadecanoic acid
(2r,3r)-rel-3-octyl-2-oxiraneoctanoic acid
IMYZYCNQZDBZBQ-UHFFFAOYSA-N
CHEBI:85661
J-015525
LMFA02000326
DTXSID90866879
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
epoxystearic acidAn epoxy fatty acid consisting of stearic (octadecanoic) acid with a single epoxide in an unspecified position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (21.43)18.7374
1990's10 (35.71)18.2507
2000's6 (21.43)29.6817
2010's2 (7.14)24.3611
2020's4 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.09 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (9.68%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (90.32%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]